Literature DB >> 6699947

Peptide maps and N-terminal sequences of polypeptides from early region 1A of human adenovirus 5.

J F Downey, C M Evelegh, P E Branton, S T Bayley.   

Abstract

Experiments exploring the reasons for a multiplicity of products from early region 1A of adenovirus 5 are described. Labeled early region 1A products from wild-type virus were synthesized in infected cells and in a cell-free system programmed with mRNA from infected cells, immunoprecipitated specifically with an antipeptide serum, E1A-C1, directed against the C-terminal sequence of E1A products, and separated by gel electrophoresis. Two-dimensional maps of [35S]methionine-labeled peptides were consistent with antigens of 52,000 daltons (52K) and 48.5K being from the 13S mRNA and antigens of 50K, 45K, and 35K from the 12S mRNA. Partial N-terminal sequences of 52K, 50K, 48.5K, and 45K synthesized in vitro showed that each of these antigens was initiated at the predicted ATG at nucleotide 560 in the DNA sequence. These results eliminate multiple initiation sites and proteolytic cleavage at the N-terminal end as sources of antigen diversity. Peptide maps and N-terminal sequences were obtained in a similar way for E1A products from the Ad5 deletion mutant dl1504, which lacks the normal initiator codon. As predicted, these polypeptides are initiated at the next ATG, 15 codons downstream in the wild-type sequence. These results are discussed in relation to Kozak's ribosomal scanning model.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699947      PMCID: PMC255577     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Large and small tumor antigens from simian virus 40 have identical amino termini mapping at 0.65 map units.

Authors:  E Paucha; A Mellor; R Harvey; A E Smith; R M Hewick; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

2.  An adenovirus type 5 early gene function regulates expression of other early viral genes.

Authors:  N Jones; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  Size and location of the transforming region in human adenovirus type 5 DNA.

Authors:  F L Graham; A J van der Eb; H L Heijneker
Journal:  Nature       Date:  1974-10-25       Impact factor: 49.962

4.  Host-range mutants of adenovirus type 5 defective for growth in HeLa cells.

Authors:  T Harrison; F Graham; J Williams
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

5.  Cis-acting induction of adenovirus transcription.

Authors:  R B Gaynor; A J Berk
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

6.  Identification of families of overlapping polypeptides coded by early "transforming" gene region 1 of human adenovirus type 2.

Authors:  M Green; W S Wold; K H Brackmann; M A Cartas
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

7.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

8.  Adenovirus type 2 early proteins synthesized in vitro and in vivo: identification in infected cells of the 38,000- to 50,000- molecular-weight protein encoded by the left end of the adenovirus type 2 genome.

Authors:  M L Harter; J B Lewis
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

9.  Structure of the adenovirus 2 early mRNAs.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

10.  In vitro translation products specified by the transforming region of adenovirus type 2.

Authors:  D N Halbert; D J Spector; H J Raskas
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

View more
  18 in total

1.  Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes.

Authors:  E Moran; B Zerler; T M Harrison; M B Mathews
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

2.  Lytic and transforming functions of individual products of the adenovirus E1A gene.

Authors:  E Moran; T Grodzicker; R J Roberts; M B Mathews; B Zerler
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Differential nuclear localization of the major adenovirus type 2 E1a proteins.

Authors:  R C Schmitt; M L Fahnestock; J B Lewis
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

4.  Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products.

Authors:  E Harlow; B R Franza; C Schley
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

5.  Mapping of functional domains in adenovirus E1A proteins.

Authors:  B Krippl; B Ferguson; N Jones; M Rosenberg; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Interactions between cell growth-regulating domains in the products of the adenovirus E1A oncogene.

Authors:  B Moran; B Zerler
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

7.  Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5.

Authors:  C Egan; T N Jelsma; J A Howe; S T Bayley; B Ferguson; P E Branton
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

8.  Stabilities and interrelations of multiple species of human adenovirus type 5 early region 1 proteins in infected and transformed cells.

Authors:  P E Branton; D T Rowe
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

9.  Translation efficiency of adenovirus early region 1A mRNAs deleted in the 5' untranslated region.

Authors:  K R Spindler; A J Berk
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

10.  A first exon-encoded domain of E1A sufficient for posttranslational modification, nuclear-localization, and induction of adenovirus E3 promoter expression in Xenopus oocytes.

Authors:  J D Richter; P Young; N C Jones; B Krippl; M Rosenberg; B Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.